Q4 2022 Holdings
Filed 2023-02-14 | 89 holdings | $688.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anaptysbio Inc(ANAB) | COM | 032724106 | $81.5M | 2,628,678 | 11.8% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $44.4M | 2,700,450 | 6.5% |
| Bluebird BIO Inc | COM | 09609G100 | $32.1M | 4,635,528 | 4.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $29.3M | 2,001,585 | 4.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $25.8M | 3,124,076 | 3.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.0M | 105,000 | 3.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $24.7M | 320,000 | 3.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $23.1M | 405,600 | 3.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $21.8M | 1,120,000 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $21.6M | 3,196,446 | 3.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $20.2M | 692,925 | 2.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $18.7M | 85,000 | 2.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.6M | 1,450,000 | 2.4% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $15.5M | 281,200 | 2.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.4M | 300,000 | 2.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $14.4M | 80,000 | 2.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.7M | 240,000 | 1.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.5M | 170,000 | 1.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $11.2M | 1,870,000 | 1.6% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $9.4M | 3,755,934 | 1.4% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $9.3M | 200,000 | 1.4% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $9.0M | 600,000 | 1.3% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $8.9M | 411,968 | 1.3% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $8.8M | 21,000 | 1.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $8.5M | 809,231 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.6M | 200,000 | 1.1% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $7.3M | 20,000 | 1.1% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $7.3M | 1,700,000 | 1.1% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $6.7M | 1,150,000 | 1.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $6.3M | 1,274,853 | 0.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $6.1M | 809,488 | 0.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.6M | 3,510,445 | 0.8% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $5.4M | 600,000 | 0.8% |
| Genfit S A | ADS | 372279109 | $5.3M | 1,197,522 | 0.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.1M | 114,950 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.0M | 110,000 | 0.7% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $4.7M | 3,470,700 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $4.5M | 30,000 | 0.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $4.4M | 36,090 | 0.6% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $4.4M | 50,000 | 0.6% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $4.2M | 216,700 | 0.6% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.9M | 392,500 | 0.6% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.8M | 447,967 | 0.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $3.7M | 95,000 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.7M | 100,000 | 0.5% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $3.7M | 1,100,000 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $3.5M | 409,463 | 0.5% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $3.5M | 118,857 | 0.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.3M | 166,203 | 0.5% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $3.2M | 300,000 | 0.5% |